Pharmacogenomics

Papers
(The H4-Index of Pharmacogenomics is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Differences in telomere length between patients with bipolar disorder and controls are influenced by lithium treatment27
Shared neoantigens: ideal targets for off-the-shelf cancer immunotherapy26
Assessing COVID-19 susceptibility through analysis of the genetic and epigenetic diversity of ACE2-mediated SARS-CoV-2 entry25
Assessment of primary care practitioners’ attitudes and interest in pharmacogenomic testing24
The clinical utility of combinatorial pharmacogenomic testing for patients with depression: a meta-analysis23
The inclusion of health data standards in the implementation of pharmacogenomics systems: a scoping review22
PARC report: a health-systems focus on reimbursement and patient access to pharmacogenomics testing21
Precision medicine in interventional cardiology: implications for antiplatelet therapy in patients undergoing percutaneous coronary intervention20
Potential of whole-genome sequencing-based pharmacogenetic profiling18
PGxKnow: a pharmacogenomics educational HoloLens application of augmented reality and artificial intelligence18
Cost–effectiveness of combinatorial pharmacogenomic testing for depression from the Canadian public payer perspective18
Strategies and settings of clinical pharmacogenetic implementation: a scoping review of pharmacogenetics programs17
Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) clinical program16
Cost avoidance related to a pharmacist-led pharmacogenomics service for the Program of All-inclusive Care for the Elderly16
Effects of the CYP2C19 LoF allele on major adverse cardiovascular events associated with clopidogrel in acute coronary syndrome patients undergoing percutaneous coronary intervention: a meta-an15
Genetic susceptibilities and prediction modeling of carbamazepine and allopurinol-induced severe cutaneous adverse reactions in Vietnamese15
Pharmacogenomics in the UK National Health Service: opportunities and challenges15
Pharmacogenomic testing to support prescribing in primary care: a structured review of implementation models15
Pharmacogenomics of methadone: a narrative review of the literature15
0.02535605430603